3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370 Recall
3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370
FDA recall Class I
Ongoing
FDA lists this Class I recall for 3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2483-2025
- Recall classification
- Class I
- Enforcement status
- Ongoing
- Initiation date
- Apr 10, 2025
- FDA report date
- Sep 24, 2025
- Quantity in commerce
- 530,470 units
- Distribution
- See key details
- FDA cause
- Device Design
What is being recalled?
3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370
Affected model & UDI checker
Search the exact identifiers published for Z-2483-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 24355 | 3M Ranger Blood/Fluid Warming High Flow Set Catalog Numbers 24355, 24370 | Check source notice | Not specified |
FDA code information
All lots with a manufacturing date after March 2022.
Why was this product recalled?
Field action to clarify the flow rates and inlet fluid temperatures, along with location of the outlet temperature for Ranger Blood/Fluid Warming High Flow Sets.
What actions did 3M COMPANY take?
An Urgent Medical Device Correction letter was sent to all their customers on 4/21/2025 to inform them that Solventum [formerly 3M Company] clarified flow rates related to the inlet fluid temperature. The device instructions for use (IFU) will be updated to reflect these changes. Customers are informed that there have been no changes to the design or composition of these products that prompted this notification. Customers are instructed to continue to use the products as indicated, considering the updated information provided in the letter. If the device is used at a flow rate outside of the updated information provided, there is a potential risk for the device to administer the fluids at a lower temperature than indicated and cause a decrease in patient temperature. Under the dire circumstances of a massive rapid infusion where high flow rates outside of the updated ranges indicated below may be used, there is a potential for hypothermia. Customers with additional questions or need to report an adverse event, are instructed to contact the Solventum [formerly 3M Health Care] Customer Helpline at 1-800-228-3957, option 6.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2483-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology